Unipr
Andy Mehrotra is an accomplished leader in the biopharmaceutical and technology sectors, currently serving as CEO of Unipr since January 2022, where a focus on optimizing research portfolios through integrated project ecosystems and artificial intelligence enhances R&D productivity. Prior to Unipr, Andy founded and led EightSpokes, a cloud-based Project Portfolio Management system aimed at accelerating drug and device development from May 2012 to December 2021. Earlier experience includes strategic roles at Sage Therapeutics, Sanofi, Abbott, Zero Corporation.Com Pty Ltd, and IMS Health, contributing to product commercialization, marketing strategies, and digital transformation. Educational credentials include master's degrees from both Massachusetts Institute of Technology and Harvard Medical School, an MBA from AGSM @ UNSW Business School, and a Bachelor of Pharmacy from Karnatak University.
This person is not in any teams
Unipr
What is Unipr? Unipr is an integrated project ecosystem and artificial intelligence platform to optimize research portfolios, manage development programs and launch projects, forecast budgets and resources, foresee risks and delays, future-proof decisions, and adapt tactics in real-time across evolving scenarios. Unipr helps increase R&D productivity, accelerate products to market, unite cross-functional teams, and use Predictive AI to future-proof your decision-making and Generative AI to reduce tactical workflows. UNIPR = Unify + Predict Why Unipr? 1. Work seamlessly with 300+ Unipr tools together in one place. 2. Reveal hidden insights within interdependent operations. 3. Unify data from multiple cloud-based project tools. 4. Make proactive decisions with Predictive AI. 5. Use Generative AI for repetitive workflows.